Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Augustyn

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|July 3, 2023
ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancersAna Martin-Vega, Svetlana Earnest, Alexander Augustyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Cell Reports|July 26, 2016
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic ProgramsMark D Borromeo, Trisha K Savage, Rahul K Kollipara, et al.
Journal of Neuro-Oncology|March 12, 2016
Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgeryZabi Wardak, Alexander Augustyn, Hong Zhu, et al.
Frontiers in Oncology|April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent PembrolizumabBrooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Oncotarget|April 23, 2015
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesisKarine Pozo, Antje Hillmann, Alexander Augustyn, et al.
Cureus|December 12, 2019
Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer DatabaseJoseph A Miccio, Vikram Jairam, Sarah Gao, et al.
The Journal of Clinical Investigation|August 9, 2016
ZEB1 drives epithelial-to-mesenchymal transition in lung cancerJill E Larsen, Vaishnavi Nathan, Jihan K Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancersAlexander Augustyn, Mark Borromeo, Tao Wang, et al.
Neuro-Oncology|January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trialsRoshal R Patel, Vivek Verma, Austin B Miller, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|July 3, 2023
ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancersAna Martin-Vega, Svetlana Earnest, Alexander Augustyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Cell Reports|July 26, 2016
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic ProgramsMark D Borromeo, Trisha K Savage, Rahul K Kollipara, et al.
Journal of Neuro-Oncology|March 12, 2016
Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgeryZabi Wardak, Alexander Augustyn, Hong Zhu, et al.
Frontiers in Oncology|April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent PembrolizumabBrooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Oncotarget|April 23, 2015
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesisKarine Pozo, Antje Hillmann, Alexander Augustyn, et al.
Cureus|December 12, 2019
Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer DatabaseJoseph A Miccio, Vikram Jairam, Sarah Gao, et al.
The Journal of Clinical Investigation|August 9, 2016
ZEB1 drives epithelial-to-mesenchymal transition in lung cancerJill E Larsen, Vaishnavi Nathan, Jihan K Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancersAlexander Augustyn, Mark Borromeo, Tao Wang, et al.
Neuro-Oncology|January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trialsRoshal R Patel, Vivek Verma, Austin B Miller, et al.
Pageof 3